Immune aspects of the pathogenesis of inflammatory bowel disease

Pharmacology and Therapeutics

Volumn 137, Issue 3, 2013, Pages 283-297

  Hisamatsu, Tadakazu ^a   Kanai, Takanori ^a   Mikami, Yohei ^a   Yoneno, Kazuaki ^a   Matsuoka, Katsuyoshi ^a   Hibi, Toshifumi ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Autophagy; Cytokines; ER stress; Innate and acquired immunity; Micobiota; Molecular targeting therapy; Susceptibility gene

Indexed keywords

ALPHA DEFENSIN; CD33 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; COLONY STIMULATING FACTOR 1; DECTIN 1; GAMMA INTERFERON; GLUCOSE REGULATED PROTEIN 78; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 23P19; INTERLEUKIN 6; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ADAPTIVE IMMUNITY; AUTOPHAGY; BACTEROIDETES; CELL COUNT; CELL DIFFERENTIATION; CELLS; CRINOPHAGY; CROHN DISEASE; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; ENDOPLASMIC RETICULUM STRESS; ENTERITIS; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GOBLET CELL; GRANULOMA; HUMAN; IMMUNE DYSREGULATION; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSTIMULATION; IMMUNOSURVEILLANCE; INNATE IMMUNITY; INTESTINE BIOPSY; INTESTINE EPITHELIUM CELL; LAMINA PROPRIA; LIPID DIET; MACROPHAGE; MEMORY T LYMPHOCYTE; NONHUMAN; OLIGOMERIZATION; PANETH CELL; PATHOGENESIS; POLARIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SALMONELLOSIS; TH1 TH2 BALANCE; TH17 CELL; ULCERATIVE COLITIS; UNFOLDED PROTEIN RESPONSE;

ANIMALS; AUTOPHAGY; ENDOPLASMIC RETICULUM STRESS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATORY BOWEL DISEASES;

EID: 84874108251     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2012.10.008     Document Type: Review

References (193)

1. E.V. Acosta-Rodriguez, G. Napolitani, A. Lanzavecchia, and F. Sallusto Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells Nat Immunol 8 2007 942 949
2. C.A. Anderson, G. Boucher, C.W. Lees, A. Franke, M. D'Amato, and K.D. Taylor Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 Nat Genet 43 2011 246 252
3. J.L. Anderson, R.J. Edney, and K. Whelan Systematic review: Faecal microbiota transplantation in the management of inflammatory bowel disease Aliment Pharmacol Ther 36 2012 503 516
4. A. Andoh, H. Imaeda, T. Aomatsu, O. Inatomi, S. Bamba, and M. Sasaki Comparison of the fecal microbiota profiles between ulcerative colitis and Crohn's disease using terminal restriction fragment length polymorphism analysis J Gastroenterol 46 2011 479 486
5. A. Andou, T. Hisamatsu, S. Okamoto, H. Chinen, N. Kamada, and T. Kobayashi Dietary histidine ameliorates murine colitis by inhibition of proinflammatory cytokine production from macrophages Gastroenterology 136 564-574 2009 e562
6. D.S. Ardelean, T. Gonska, S. Wires, E. Cutz, A. Griffiths, and E. Harvey Severe ulcerative colitis after rituximab therapy Pediatrics 126 2010 e243 e246
7. M. Arumugam, J. Raes, E. Pelletier, D. Le Paslier, T. Yamada, and D.R. Mende Enterotypes of the human gut microbiome Nature 473 2011 174 180
8. K. Atarashi, J. Nishimura, T. Shima, Y. Umesaki, M. Yamamoto, and M. Onoue ATP drives lamina propria T (H)17 cell differentiation Nature 455 2008 808 812
9. K. Atarashi, T. Tanoue, T. Shima, A. Imaoka, T. Kuwahara, and Y. Momose Induction of colonic regulatory T cells by indigenous Clostridium species Science 331 2011 337 341
10. J.C. Barrett, S. Hansoul, D.L. Nicolae, J.H. Cho, R.H. Duerr, and J.D. Rioux Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease Nat Genet 40 2008 955 962
11. A. Bertolotti, X. Wang, I. Novoa, R. Jungreis, K. Schlessinger, and J.H. Cho Increased sensitivity to dextran sodium sulfate colitis in IRE1beta-deficient mice J Clin Invest 107 2001 585 593
12. E. Bettelli, Y. Carrier, W. Gao, T. Korn, T.B. Strom, and M. Oukka Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells Nature 441 2006 235 238
13. E. Bettelli, T. Korn, M. Oukka, and V.K. Kuchroo Induction and effector functions of T (H)17 cells Nature 453 2008 1051 1057
14. M. Boirivant, I.J. Fuss, A. Chu, and W. Strober Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4 J Exp Med 188 1998 1929 1939
15. J. Boudeau, A.L. Glasser, E. Masseret, B. Joly, and A. Darfeuille-Michaud Invasive ability of an Escherichia coli strain isolated from the ileal mucosa of a patient with Crohn's disease Infect Immun 67 1999 4499 4509
16. S. Buonocore, P.P. Ahern, H.H. Uhlig, I.I. Ivanov, D.R. Littman, and K.J. Maloy Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology Nature 464 2010 1371 1375
17. K. Cadwell, J.Y. Liu, S.L. Brown, H. Miyoshi, J. Loh, and J.K. Lennerz A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells Nature 456 2008 259 263
18. K. Cadwell, K.K. Patel, N.S. Maloney, T.C. Liu, A.C. Ng, and C.E. Storer Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine Cell 141 2010 1135 1145
19. E. Cario, G. Gerken, and D.K. Podolsky Toll-like receptor 2 controls mucosal inflammation by regulating epithelial barrier function Gastroenterology 132 2007 1359 1374
20. M.G. Cecchini, M.G. Dominguez, S. Mocci, A. Wetterwald, R. Felix, and H. Fleisch Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse Development 120 1994 1357 1372
21. M. Cella, A. Fuchs, W. Vermi, F. Facchetti, K. Otero, and J.K. Lennerz A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity Nature 457 2009 722 725
22. B. Chassaing, N. Rolhion, A. de Vallee, S.Y. Salim, M. Prorok-Hamon, and C. Neut Crohn disease - associated adherent-invasive E. coli bacteria target mouse and human Peyer's patches via long polar fimbriae J Clin Invest 121 2011 966 975
23. H. Chinen, K. Matsuoka, T. Sato, N. Kamada, S. Okamoto, and T. Hisamatsu Lamina propria c-kit+ immune precursors reside in human adult intestine and differentiate into natural killer cells Gastroenterology 133 2007 559 573
24. J.H. Cho The genetics and immunopathogenesis of inflammatory bowel disease Nat Rev Immunol 8 2008 458 466
25. J.F. Colombel, W.J. Sandborn, P. Rutgeerts, R. Enns, S.B. Hanauer, and R. Panaccione Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial Gastroenterology 132 2007 52 65
26. M. Colonna Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity Immunity 31 2009 15 23
27. M.P. Conte, S. Schippa, I. Zamboni, M. Penta, F. Chiarini, and L. Seganti Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease Gut 55 2006 1760 1767
28. D.J. Cua, and C.M. Tato Innate IL-17-producing cells: The sentinels of the immune system Nat Rev Immunol 10 2010 479 489
29. T. Cupedo, N.K. Crellin, N. Papazian, E.J. Rombouts, K. Weijer, and J.L. Grogan Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+CD127+natural killer-like cells Nat Immunol 10 2009 66 74
30. A. Darfeuille-Michaud, J. Boudeau, P. Bulois, C. Neut, A.L. Glasser, and N. Barnich High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease Gastroenterology 127 2004 412 421
31. A. Darfeuille-Michaud, C. Neut, N. Barnich, E. Lederman, P. Di Martino, and P. Desreumaux Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease Gastroenterology 115 1998 1405 1413
32. T.L. Denning, Y.C. Wang, S.R. Patel, I.R. Williams, and B. Pulendran Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses Nat Immunol 8 2007 1086 1094
33. B. Derkx, J. Taminiau, S. Radema, A. Stronkhorst, C. Wortel, and G. Tytgat Tumour-necrosis-factor antibody treatment in Crohn's disease Lancet 342 1993 173 174
34. S. Devkota, Y. Wang, M.W. Musch, V. Leone, H. Fehlner-Peach, and A. Nadimpalli Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice Nature 487 2012 104 108
35. J.P. Di Santo, C.A. Vosshenrich, and N. Satoh-Takayama A 'natural' way to provide innate mucosal immunity Curr Opin Immunol 22 2010 435 441
36. G. Eberl, and D.R. Littman Thymic origin of intestinal alphabeta T cells revealed by fate mapping of RORgammat+cells Science 305 2004 248 251
37. G. Eberl, S. Marmon, M.J. Sunshine, P.D. Rennert, Y. Choi, and D.R. Littman An essential function for the nuclear receptor RORgamma (t) in the generation of fetal lymphoid tissue inducer cells Nat Immunol 5 2004 64 73
38. E. Elinav, T. Strowig, A.L. Kau, J. Henao-Mejia, C.A. Thaiss, and C.J. Booth NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis Cell 145 2011 745 757
39. C.O. Elson, Y. Cong, C.T. Weaver, T.R. Schoeb, T.K. McClanahan, and R.B. Fick Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice Gastroenterology 132 2007 2359 2370
40. B.G. Feagan, W.J. Sandborn, S. Hass, T. Niecko, and J. White Health-related quality of life during natalizumab maintenance therapy for Crohn's disease Am J Gastroenterol 102 2007 2737 2746
41. D.N. Frank, C.E. Robertson, C.M. Hamm, Z. Kpadeh, T. Zhang, and H. Chen Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases Inflamm Bowel Dis 17 2011 179 184
42. D.N. Frank, A.L. St Amand, R.A. Feldman, E.C. Boedeker, N. Harpaz, and N.R. Pace Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases Proc Natl Acad Sci U S A 104 2007 13780 13785
43. A. Franke, D.P. McGovern, J.C. Barrett, K. Wang, G.L. Radford-Smith, and T. Ahmad Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci Nat Genet 42 2010 1118 1125
44. T. Fujii, T. Tomita, T. Kanai, Y. Nemoto, T. Totsuka, and N. Sakamoto FTY720 suppresses the development of colitis in lymphoid-null mice by modulating the trafficking of colitogenic CD4+T cells in bone marrow Eur J Immunol 38 2008 3290 3303
45. S. Fujino, A. Andoh, S. Bamba, A. Ogawa, K. Hata, and Y. Araki Increased expression of interleukin 17 in inflammatory bowel disease Gut 52 2003 65 70
46. N. Fujita, T. Saitoh, S. Kageyama, S. Akira, T. Noda, and T. Yoshimori Differential involvement of Atg16L1 in Crohn disease and canonical autophagy: Analysis of the organization of the Atg16L1 complex in fibroblasts J Biol Chem 284 2009 32602 32609
47. I.J. Fuss, F. Heller, M. Boirivant, F. Leon, M. Yoshida, and S. Fichtner-Feigl Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis J Clin Invest 113 2004 1490 1497
48. W.S. Garrett, G.M. Lord, S. Punit, G. Lugo-Villarino, S.K. Mazmanian, and S. Ito Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system Cell 131 2007 33 45
49. A. Geremia, C.V. Arancibia-Carcamo, M.P. Fleming, N. Rust, B. Singh, and N.J. Mortensen IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease J Exp Med 208 2011 1127 1133
50. K. Ghoreschi, A. Laurence, X.P. Yang, C.M. Tato, M.J. McGeachy, and J.E. Konkel Generation of pathogenic T (H) 17 cells in the absence of TGF-beta signalling Nature 467 2010 967 971
51. E.O. Glocker, N. Frede, M. Perro, N. Sebire, M. Elawad, and N. Shah Infant colitis-it's in the genes Lancet 376 2010 1272
52. E.O. Glocker, D. Kotlarz, K. Boztug, E.M. Gertz, A.A. Schaffer, and F. Noyan Inflammatory bowel disease and mutations affecting the interleukin-10 receptor N Engl J Med 361 2009 2033 2045
53. M. Goetz, R. Atreya, M. Ghalibafian, P.R. Galle, and M.F. Neurath Exacerbation of ulcerative colitis after rituximab salvage therapy Inflamm Bowel Dis 13 2007 1365 1368
54. A.L. Goodman, G. Kallstrom, J.J. Faith, A. Reyes, A. Moore, and G. Dantas Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice Proc Natl Acad Sci U S A 108 2011 6252 6257
55. S. Gordon, and P.R. Taylor Monocyte and macrophage heterogeneity Nat Rev Immunol 5 2005 953 964
56. C. Gunther, E. Martini, N. Wittkopf, K. Amann, B. Weigmann, and H. Neumann Caspase-8 regulates TNF-alpha-induced epithelial necroptosis and terminal ileitis Nature 477 2011 335 339
57. J. Hampe, A. Franke, P. Rosenstiel, A. Till, M. Teuber, and K. Huse A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1 Nat Genet 39 2007 207 211
58. S.B. Hanauer, B.G. Feagan, G.R. Lichtenstein, L.F. Mayer, S. Schreiber, and J.F. Colombel Maintenance infliximab for Crohn's disease: The ACCENT I randomised trial Lancet 359 2002 1541 1549
59. S.B. Hanauer, and D.H. Present The state of the art in the management of inflammatory bowel disease Rev Gastroenterol Disord 3 2003 81 92
60. S.B. Hanauer, W.J. Sandborn, P. Rutgeerts, R.N. Fedorak, M. Lukas, and D. MacIntosh Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: The CLASSIC-I trial Gastroenterology 130 2006 323 333 (quiz 591)
61. F. Heller, I.J. Fuss, E.E. Nieuwenhuis, R.S. Blumberg, and W. Strober Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells Immunity 17 2002 629 638
62. T. Hirotani, P.Y. Lee, H. Kuwata, M. Yamamoto, M. Matsumoto, and I. Kawase The nuclear IkappaB protein IkappaBNS selectively inhibits lipopolysaccharide-induced IL-6 production in macrophages of the colonic lamina propria J Immunol 174 2005 3650 3657
63. T. Hisamatsu, S. Okamoto, M. Hashimoto, T. Muramatsu, A. Andou, and M. Uo Novel, objective, multivariate biomarkers composed of plasma amino acid profiles for the diagnosis and assessment of inflammatory bowel disease PLoS One 7 2012 e31131
64. J.P. Hugot, M. Chamaillard, H. Zouali, S. Lesage, J.P. Cezard, and J. Belaiche Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease Nature 411 2001 599 603
65. J.U. Igietseme, G.A. Ananaba, J. Bolier, S. Bowers, T. Moore, and T. Belay Suppression of endogenous IL-10 gene expression in dendritic cells enhances antigen presentation for specific Th1 induction: Potential for cellular vaccine development J Immunol 164 2000 4212 4219
66. I.D. Iliev, V.A. Funari, K.D. Taylor, Q. Nguyen, C.N. Reyes, and S.P. Strom Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis Science 336 2012 1314 1317
67. N. Inoue, K. Tamura, Y. Kinouchi, Y. Fukuda, S. Takahashi, and Y. Ogura Lack of common NOD2 variants in Japanese patients with Crohn's disease Gastroenterology 123 2002 86 91
68. I.I. Ivanov, K. Atarashi, N. Manel, E.L. Brodie, T. Shima, and U. Karaoz Induction of intestinal Th17 cells by segmented filamentous bacteria Cell 139 2009 485 498
69. N. Kamada, T. Hisamatsu, H. Honda, T. Kobayashi, H. Chinen, and M.T. Kitazume Human CD14+ macrophages in intestinal lamina propria exhibit potent antigen-presenting ability J Immunol 183 2009 1724 1731
70. N. Kamada, T. Hisamatsu, H. Honda, T. Kobayashi, H. Chinen, and T. Takayama TL1A produced by lamina propria macrophages induces Th1 and Th17 immune responses in cooperation with IL-23 in patients with Crohn's disease Inflamm Bowel Dis 16 2010 568 575
71. N. Kamada, T. Hisamatsu, S. Okamoto, H. Chinen, T. Kobayashi, and T. Sato Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis J Clin Invest 118 2008 2269 2280
72. N. Kamada, T. Hisamatsu, S. Okamoto, T. Sato, K. Matsuoka, and K. Arai Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to bacteria J Immunol 175 2005 6900 6908
73. T. Kanai, M. Watanabe, A. Okazawa, T. Sato, M. Yamazaki, and S. Okamoto Macrophage-derived IL-18-mediated intestinal inflammation in the murine model of Crohn's disease Gastroenterology 121 2001 875 888
74. A. Kaser, A.H. Lee, A. Franke, J.N. Glickman, S. Zeissig, and H. Tilg XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease Cell 134 2008 743 756
75. R. Kawashima, Y.I. Kawamura, R. Kato, N. Mizutani, N. Toyama-Sorimachi, and T. Dohi IL-13 receptor alpha2 promotes epithelial cell regeneration from radiation-induced small intestinal injury in mice Gastroenterology 131 2006 130 141
76. R. Kawashima, Y.I. Kawamura, T. Oshio, A. Son, M. Yamazaki, and T. Hagiwara Interleukin-13 damages intestinal mucosa via TWEAK and Fn14 in mice-a pathway associated with ulcerative colitis Gastroenterology 141 2119-2129 2011 e2118
77. R. Kellermayer, S.A. Mir, D. Nagy-Szakal, S.B. Cox, S.E. Dowd, and J.L. Kaplan Microbiota separation and C-reactive protein elevation in treatment naive pediatric granulomatous Crohn disease J Pediatr Gastroenterol Nutr 55 2012 243 250
78. K.S. Kobayashi, M. Chamaillard, Y. Ogura, O. Henegariu, N. Inohara, and G. Nunez Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract Science 307 2005 731 734
79. T. Kobayashi, M. Naganuma, S. Okamoto, T. Hisamatsu, N. Inoue, and H. Ichikawa Rapid endoscopic improvement is important for 1-year avoidance of colectomy but not for the long-term prognosis in cyclosporine A treatment for ulcerative colitis J Gastroenterol 45 2010 1129 1137
80. T. Kobayashi, S. Okamoto, T. Hisamatsu, N. Kamada, H. Chinen, and R. Saito IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease Gut 57 2008 1682 1689
81. D. Kotlarz, R. Beier, D. Murugan, J. Diestelhorst, O. Jensen, and K. Boztug Loss of interleukin-10 signaling and infantile inflammatory bowel disease: Implications for diagnosis and therapy Gastroenterology 143 2012 347 355
82. R. Kuhn, J. Lohler, D. Rennick, K. Rajewsky, and W. Muller Interleukin-10-deficient mice develop chronic enterocolitis Cell 75 1993 263 274
83. Y.K. Lee, H. Turner, C.L. Maynard, J.R. Oliver, D. Chen, and C.O. Elson Late developmental plasticity in the T helper 17 lineage Immunity 30 2009 92 107
84. K. Leiper, K. Martin, A. Ellis, S. Subramanian, A.J. Watson, and S.E. Christmas Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis Gut 60 2011 1520 1526
85. M. Leppkes, C. Becker, I.I. Ivanov, S. Hirth, S. Wirtz, and C. Neufert RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F Gastroenterology 136 2009 257 267
86. E. Li, C.M. Hamm, A.S. Gulati, R.B. Sartor, H. Chen, and X. Wu Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition PLoS One 7 2012 e26284
87. S. Lichtiger, D.H. Present, A. Kornbluth, I. Gelernt, J. Bauer, and G. Galler Cyclosporine in severe ulcerative colitis refractory to steroid therapy N Engl J Med 330 1994 1841 1845
88. N. Manel, D. Unutmaz, and D.R. Littman The differentiation of human T (H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat Nat Immunol 9 2008 641 649
89. P.R. Mangan, L.E. Harrington, D.B. O'Quinn, W.S. Helms, D.C. Bullard, and C.O. Elson Transforming growth factor-beta induces development of the T (H) 17 lineage Nature 441 2006 231 234
90. P.J. Mannon, I.J. Fuss, L. Mayer, C.O. Elson, W.J. Sandborn, and D. Present Anti-interleukin-12 antibody for active Crohn's disease N Engl J Med 351 2004 2069 2079
91. A. Mantovani, A. Sica, S. Sozzani, P. Allavena, A. Vecchi, and M. Locati The chemokine system in diverse forms of macrophage activation and polarization Trends Immunol 25 2004 677 686
92. H.M. Martin, B.J. Campbell, C.A. Hart, C. Mpofu, M. Nayar, and R. Singh Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer Gastroenterology 127 2004 80 93
93. C. Martinez, M. Antolin, J. Santos, A. Torrejon, F. Casellas, and N. Borruel Unstable composition of the fecal microbiota in ulcerative colitis during clinical remission Am J Gastroenterol 103 2008 643 648
94. M. Martinez-Medina, X. Aldeguer, M. Lopez-Siles, F. Gonzalez-Huix, C. Lopez-Oliu, and G. Dahbi Molecular diversity of Escherichia coli in the human gut: New ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn's disease Inflamm Bowel Dis 15 2009 872 882
95. K. Matsuoka, N. Inoue, T. Sato, S. Okamoto, T. Hisamatsu, and Y. Kishi T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease Gut 53 2004 1303 1308
96. S.K. Mazmanian, J.L. Round, and D.L. Kasper A microbial symbiosis factor prevents intestinal inflammatory disease Nature 453 2008 620 625
97. M.J. McGeachy, K.S. Bak-Jensen, Y. Chen, C.M. Tato, W. Blumenschein, and T. McClanahan TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T (H)-17 cell-mediated pathology Nat Immunol 8 2007 1390 1397
98. D.P. McGovern, A. Gardet, L. Torkvist, P. Goyette, J. Essers, and K.D. Taylor Genome-wide association identifies multiple ulcerative colitis susceptibility loci Nat Genet 42 2010 332 337
99. R.E. Mebius, P. Rennert, and I.L. Weissman Developing lymph nodes collect CD4+CD3- LTbeta+cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells Immunity 7 1997 493 504
100. Y. Mikami, T. Kanai, T. Sujino, Y. Ono, A. Hayashi, and A. Okazawa Competition between colitogenic Th1 and Th17 cells contributes to the amelioration of colitis Eur J Immunol 40 2010 2409 2422
101. E. Mizoguchi, A. Mizoguchi, F.I. Preffer, and A.K. Bhan Regulatory role of mature B cells in a murine model of inflammatory bowel disease Int Immunol 12 2000 597 605
102. A. Mizoguchi, E. Mizoguchi, H. Takedatsu, R.S. Blumberg, and A.K. Bhan Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation Immunity 16 2002 219 230
103. A. Mizoguchi, A. Ogawa, H. Takedatsu, K. Sugimoto, Y. Shimomura, and K. Shirane Dependence of intestinal granuloma formation on unique myeloid DC-like cells J Clin Invest 117 2007 605 615
104. F. Mocciaro, S. Renna, A. Orlando, G. Rizzuto, E. Sinagra, and E. Orlando Cyclosporine or infliximab as rescue therapy in severe refractory ulcerative colitis: Early and long-term data from a retrospective observational study J Crohns Colitis 6 2012 681 686
105. P. Mombaerts, E. Mizoguchi, M.J. Grusby, L.H. Glimcher, A.K. Bhan, and S. Tonegawa Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice Cell 75 1993 274 282
106. D.M. Mosser The many faces of macrophage activation J Leukoc Biol 73 2003 209 212
107. H. Naruse, T. Hisamatsu, Y. Yamauchi, J.E. Chang, K. Matsuoka, and M.T. Kitazume Intracellular bacteria recognition contributes to maximal interleukin (IL)-12 production by IL-10-deficient macrophages Clin Exp Immunol 164 2011 137 144
108. Y. Nemoto, T. Kanai, S. Makita, R. Okamoto, T. Totsuka, and K. Takeda Bone marrow retaining colitogenic CD4+T cells may be a pathogenic reservoir for chronic colitis Gastroenterology 132 2007 176 189
109. A. Nenci, C. Becker, A. Wullaert, R. Gareus, G. van Loo, and S. Danese Epithelial NEMO links innate immunity to chronic intestinal inflammation Nature 446 2007 557 561
110. S. Nuding, K. Fellermann, J. Wehkamp, and E.F. Stange Reduced mucosal antimicrobial activity in Crohn's disease of the colon Gut 56 2007 1240 1247
111. W. O'Connor Jr., M. Kamanaka, C.J. Booth, T. Town, S. Nakae, and Y. Iwakura A protective function for interleukin 17A in T cell-mediated intestinal inflammation Nat Immunol 10 2009 603 609
112. H. Ogata, J. Kato, F. Hirai, N. Hida, T. Matsui, and T. Matsumoto Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis Inflamm Bowel Dis 18 2012 803 808
113. H. Ogata, T. Matsui, M. Nakamura, M. Iida, M. Takazoe, and Y. Suzuki A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis Gut 55 2006 1255 1262
114. A. Ogawa, A. Andoh, Y. Araki, T. Bamba, and Y. Fujiyama Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice Clin Immunol 110 2004 55 62
115. Y. Ogura, D.K. Bonen, N. Inohara, D.L. Nicolae, F.F. Chen, and R. Ramos A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease Nature 411 2001 603 606
116. T. Olszak, D. An, S. Zeissig, M.P. Vera, J. Richter, and A. Franke Microbial exposure during early life has persistent effects on natural killer T cell function Science 336 2012 489 493
117. Y. Ono, T. Kanai, T. Sujino, Y. Nemoto, Y. Kanai, and Y. Mikami T-helper 17 and interleukin-17-producing lymphoid tissue inducer-like T cells make different contributions to colitis in mice Gastroenterology 2012 10.1053/j.gastro.2012.07.108 (Epub ahead of print)
118. E. Papa, M. Docktor, C. Smillie, S. Weber, S.P. Preheim, and D. Gevers Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease PLoS One 7 2012 e39242
119. M. Parkes, J.C. Barrett, N.J. Prescott, M. Tremelling, C.A. Anderson, and S.A. Fisher Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility Nat Genet 39 2007 830 832
120. Y. Picornell, L. Mei, K. Taylor, H. Yang, S.R. Targan, and J.I. Rotter TNFSF15 is an ethnic-specific IBD gene Inflamm Bowel Dis 13 2007 1333 1338
121. T.S. Plantinga, T.O. Crisan, M. Oosting, F.L. van de Veerdonk, D.J. de Jong, and D.J. Philpott Crohn's disease-associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2 Gut 60 2011 1229 1235
122. N.J. Prescott, S.A. Fisher, A. Franke, J. Hampe, C.M. Onnie, and D. Soars A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5 Gastroenterology 132 2007 1665 1671
123. D.H. Present, P. Rutgeerts, S. Targan, S.B. Hanauer, L. Mayer, and R.A. van Hogezand Infliximab for the treatment of fistulas in patients with Crohn's disease N Engl J Med 340 1999 1398 1405
124. W. Reinisch, W.J. Sandborn, D.W. Hommes, G. D'Haens, S. Hanauer, and S. Schreiber Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: Results of a randomised controlled trial Gut 60 2011 780 787
125. M. Rimoldi, M. Chieppa, V. Salucci, F. Avogadri, A. Sonzogni, and G.M. Sampietro Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells Nat Immunol 6 2005 507 514
126. J.D. Rioux, R.J. Xavier, K.D. Taylor, M.S. Silverberg, P. Goyette, and A. Huett Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis Nat Genet 39 2007 596 604
127. G. Rogler, M. Hausmann, D. Vogl, E. Aschenbrenner, T. Andus, and W. Falk Isolation and phenotypic characterization of colonic macrophages Clin Exp Immunol 112 1998 205 215
128. J.L. Round, S.M. Lee, J. Li, G. Tran, B. Jabri, and T.A. Chatila The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota Science 332 2011 974 977
129. J.L. Round, and S.K. Mazmanian Inducible Foxp3+regulatory T-cell development by a commensal bacterium of the intestinal microbiota Proc Natl Acad Sci U S A 107 2010 12204 12209
130. P. Rutgeerts, G. D'Haens, S. Targan, E. Vasiliauskas, S.B. Hanauer, and D.H. Present Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease Gastroenterology 117 1999 761 769
131. P. Rutgeerts, W.J. Sandborn, B.G. Feagan, W. Reinisch, A. Olson, and J. Johanns Infliximab for induction and maintenance therapy for ulcerative colitis N Engl J Med 353 2005 2462 2476
132. A. Sakuraba, T. Sato, N. Kamada, M. Kitazume, A. Sugita, and T. Hibi Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease Gastroenterology 137 2009 1736 1745
133. N.H. Salzman, K. Hung, D. Haribhai, H. Chu, J. Karlsson-Sjoberg, and E. Amir Enteric defensins are essential regulators of intestinal microbial ecology Nat Immunol 11 2010 76 83
134. W.J. Sandborn, J.F. Colombel, R. Enns, B.G. Feagan, S.B. Hanauer, and I.C. Lawrance Natalizumab induction and maintenance therapy for Crohn's disease N Engl J Med 353 2005 1912 1925
135. W.J. Sandborn, B.G. Feagan, R.N. Fedorak, E. Scherl, M.R. Fleisher, and S. Katz A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease Gastroenterology 135 2008 1130 1141
136. W.J. Sandborn, B.G. Feagan, S. Stoinov, P.J. Honiball, P. Rutgeerts, and D. Mason Certolizumab pegol for the treatment of Crohn's disease N Engl J Med 357 2007 228 238
137. W.J. Sandborn, G. van Assche, W. Reinisch, J.F. Colombel, G. D'Haens, and D.C. Wolf Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis Gastroenterology 142 257-265 2012 e251 e253
138. N. Satoh-Takayama, C.A. Vosshenrich, S. Lesjean-Pottier, S. Sawa, M. Lochner, and F. Rattis Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense Immunity 29 2008 958 970
139. S. Sawa, M. Cherrier, M. Lochner, N. Satoh-Takayama, H.J. Fehling, and F. Langa Lineage relationship analysis of RORgammat+innate lymphoid cells Science 330 2010 665 669
140. M. Schenk, A. Bouchon, F. Seibold, and C. Mueller TREM-1-expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases J Clin Invest 117 2007 3097 3106
141. M. Schenk, and C. Mueller Adaptations of intestinal macrophages to an antigen-rich environment Semin Immunol 19 2007 84 93
142. S. Schreiber, P. Rutgeerts, R.N. Fedorak, M. Khaliq-Kareemi, M.A. Kamm, and M. Boivin A randomized, placebo-controlled trial of certolizumab pegol (CDP870) for treatment of Crohn's disease Gastroenterology 129 2005 807 818
143. R.K. Sellon, S. Tonkonogy, M. Schultz, L.A. Dieleman, W. Grenther, and E. Balish Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice Infect Immun 66 1998 5224 5231
144. J. Shi, S. Aono, W. Lu, A.J. Ouellette, X. Hu, and Y. Ji A novel role for defensins in intestinal homeostasis: Regulation of IL-1beta secretion J Immunol 179 2007 1245 1253
145. F.D. Shi, H.G. Ljunggren, A. La Cava, and L. Van Kaer Organ-specific features of natural killer cells Nat Rev Immunol 11 2011 658 671
146. T. Shinohara, Y. Nemoto, T. Kanai, K. Kameyama, R. Okamoto, and K. Tsuchiya Upregulated IL-7 receptor alpha expression on colitogenic memory CD4+T cells may participate in the development and persistence of chronic colitis J Immunol 186 2011 2623 2632
147. M. Sjoberg, A. Walch, M. Meshkat, A. Gustavsson, G. Jarnerot, and H. Vogelsang Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: A retrospective observational study Inflamm Bowel Dis 18 2012 212 218
148. P.D. Smith, L.E. Smythies, M. Mosteller-Barnum, D.A. Sibley, M.W. Russell, and M. Merger Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities J Immunol 167 2001 2651 2656
149. L.E. Smythies, M. Sellers, R.H. Clements, M. Mosteller-Barnum, G. Meng, and W.H. Benjamin Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity J Clin Invest 115 2005 66 75
150. H. Sokol, P. Seksik, L. Rigottier-Gois, C. Lay, P. Lepage, and I. Podglajen Specificities of the fecal microbiota in inflammatory bowel disease Inflamm Bowel Dis 12 2006 106 111
151. G.F. Sonnenberg, L.A. Monticelli, T. Alenghat, T.C. Fung, N.A. Hutnick, and J. Kunisawa Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria Science 336 2012 1321 1325
152. G.F. Sonnenberg, L.A. Monticelli, M.M. Elloso, L.A. Fouser, and D. Artis CD4 (+) lymphoid tissue-inducer cells promote innate immunity in the gut Immunity 34 2011 122 134
153. H. Spits, and J.P. Di Santo The expanding family of innate lymphoid cells: Regulators and effectors of immunity and tissue remodeling Nat Immunol 12 2011 21 27
154. N. Steck, M. Hoffmann, I.G. Sava, S.C. Kim, H. Hahne, and S.L. Tonkonogy Enterococcus faecalis metalloprotease compromises epithelial barrier and contributes to intestinal inflammation Gastroenterology 141 2011 959 971
155. L. Steinman A rush to judgment on Th17 J Exp Med 205 2008 1517 1522
156. B. Stockinger, and M. Veldhoen Differentiation and function of Th17 T cells Curr Opin Immunol 19 2007 281 286
157. K. Sugimoto, A. Ogawa, E. Mizoguchi, Y. Shimomura, A. Andoh, and A.K. Bhan IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis J Clin Invest 118 2008 534 544
158. T. Sujino, T. Kanai, Y. Ono, Y. Mikami, A. Hayashi, and T. Doi Regulatory T cells suppress development of colitis, blocking differentiation of T-helper 17 into alternative T-helper 1 cells Gastroenterology 141 2011 1014 1023
159. A. Swidsinski, A. Ladhoff, A. Pernthaler, S. Swidsinski, V. Loening-Baucke, and M. Ortner Mucosal flora in inflammatory bowel disease Gastroenterology 122 2002 44 54
160. Y. Takada, T. Hisamatsu, N. Kamada, M.T. Kitazume, H. Honda, and Y. Oshima Monocyte chemoattractant protein-1 contributes to gut homeostasis and intestinal inflammation by composition of IL-10-producing regulatory macrophage subset J Immunol 184 2010 2671 2676
161. H. Takaishi, T. Matsuki, A. Nakazawa, T. Takada, S. Kado, and T. Asahara Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease Int J Med Microbiol 298 2008 463 472
162. H. Takatori, Y. Kanno, W.T. Watford, C.M. Tato, G. Weiss, and I.I. Ivanov Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22 J Exp Med 206 2009 35 41
163. T. Takayama, N. Kamada, H. Chinen, S. Okamoto, M.T. Kitazume, and J. Chang Imbalance of NKp44 (+) NKp46(-) and NKp44(-)NKp46 (+) natural killer cells
164. H. Tanabe, T. Ayabe, A. Maemoto, C. Ishikawa, Y. Inaba, and R. Sato Denatured human alpha-defensin attenuates the bactericidal activity and the stability against enzymatic digestion Biochem Biophys Res Commun 358 2007 349 355
165. S.R. Targan, B.G. Feagan, R.N. Fedorak, B.A. Lashner, R. Panaccione, and D.H. Present Natalizumab for the treatment of active Crohn's disease: Results of the ENCORE Trial Gastroenterology 132 2007 1672 1683
166. S.R. Targan, S.B. Hanauer, S.J. van Deventer, L. Mayer, D.H. Present, and T. Braakman A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease.Crohn's Disease cA2 Study Group N Engl J Med 337 1997 1029 1035
167. E. Thachil, J.P. Hugot, B. Arbeille, R. Paris, A. Grodet, and M. Peuchmaur Abnormal activation of autophagy-induced crinophagy in Paneth cells from patients with Crohn's disease Gastroenterology 142 1097-1099 2012 e1094
168. R. Thiebaut, S. Kotti, C. Jung, F. Merlin, J.F. Colombel, and M. Lemann TNFSF15 polymorphisms are associated with susceptibility to inflammatory bowel disease in a new European cohort Am J Gastroenterol 104 2009 384 391
169. T. Tomita, T. Kanai, Y. Nemoto, T. Fujii, K. Nozaki, and R. Okamoto Colitogenic CD4+effector-memory T cells actively recirculate in chronic colitic mice Inflamm Bowel Dis 14 2008 1630 1640
170. T. Tomita, T. Kanai, Y. Nemoto, T. Totsuka, R. Okamoto, and K. Tsuchiya Systemic, but not intestinal, IL-7 is essential for the persistence of chronic colitis J Immunol 180 2008 383 390
171. T. Totsuka, T. Kanai, Y. Nemoto, S. Makita, R. Okamoto, and K. Tsuchiya IL-7 is essential for the development and the persistence of chronic colitis J Immunol 178 2007 4737 4748
172. M. Tremelling, C. Berzuini, D. Massey, F. Bredin, C. Price, and C. Dawson Contribution of TNFSF15 gene variants to Crohn's disease susceptibility confirmed in UK population Inflamm Bowel Dis 14 2008 733 737
173. M. Uo, T. Hisamatsu, J. Miyoshi, D. Kaito, K. Yoneno, and M.T. Kitazume Mucosal CXCR4+IgG plasma cells contribute to the pathogenesis of human ulcerative colitis through FcγR-mediated CD14 macrophage activation Gut 2012, Sep 26
174. S. Vaishnava, M. Yamamoto, K.M. Severson, K.A. Ruhn, X. Yu, and O. Koren The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine Science 334 2011 255 258
175. G. Van Assche, M. Van Ranst, R. Sciot, B. Dubois, S. Vermeire, and M. Noman Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease N Engl J Med 353 2005 362 368
176. H.M. van Dullemen, S.J. van Deventer, D.W. Hommes, H.A. Bijl, J. Jansen, and G.N. Tytgat Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2) Gastroenterology 109 1995 129 135
177. M. Veldhoen, R.J. Hocking, C.J. Atkins, R.M. Locksley, and B. Stockinger TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells Immunity 24 2006 179 189
178. E. von Mutius Allergies, infections and the hygiene hypothesis-the epidemiological evidence Immunobiology 212 2007 433 439
179. P. Walter, and D. Ron The unfolded protein response: From stress pathway to homeostatic regulation Science 334 2011 1081 1086
180. N. Watanabe, K. Ikuta, K. Okazaki, H. Nakase, Y. Tabata, and M. Matsuura Elimination of local macrophages in intestine prevents chronic colitis in interleukin-10-deficient mice Dig Dis Sci 48 2003 408 414
181. C.T. Weaver, L.E. Harrington, P.R. Mangan, M. Gavrieli, and K.M. Murphy Th17: An effector CD4 T cell lineage with regulatory T cell ties Immunity 24 2006 677 688
182. J. Wehkamp, N.H. Salzman, E. Porter, S. Nuding, M. Weichenthal, and R.E. Petras Reduced Paneth cell alpha-defensins in ileal Crohn's disease Proc Natl Acad Sci U S A 102 2005 18129 18134
183. Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls Nature 447 2007 661 678
184. F. Wiede, B.J. Shields, S.H. Chew, K. Kyparissoudis, C. van Vliet, and S. Galic T cell protein tyrosine phosphatase attenuates T cell signaling to maintain tolerance in mice J Clin Invest 121 2011 4758 4774
185. M.T. Wiekowski, M.W. Leach, E.W. Evans, L. Sullivan, S.C. Chen, and G. Vassileva Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death J Immunol 166 2001 7563 7570
186. R.J. Xavier, and D.K. Podolsky Unravelling the pathogenesis of inflammatory bowel disease Nature 448 2007 427 434
187. K. Yamazaki, D. McGovern, J. Ragoussis, M. Paolucci, H. Butler, and D. Jewell Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease Hum Mol Genet 14 2005 3499 3506
188. K. Yamazaki, Y. Onouchi, M. Takazoe, M. Kubo, Y. Nakamura, and A. Hata Association analysis of genetic variants in IL23R, ATG16L1 and 5p13.1 loci with Crohn's disease in Japanese patients J Hum Genet 52 2007 575 583
189. D. Yen, J. Cheung, H. Scheerens, F. Poulet, T. McClanahan, and B. McKenzie IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6 J Clin Invest 116 2006 1310 1316
190. C. Zaph, A.E. Troy, B.C. Taylor, L.D. Berman-Booty, K.J. Guild, and Y. Du Epithelial-cell-intrinsic IKK-beta expression regulates intestinal immune homeostasis Nature 446 2007 552 556
191. S. Zeissig, N. Burgel, D. Gunzel, J. Richter, J. Mankertz, and U. Wahnschaffe Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease Gut 56 2007 61 72
192. Z. Zhang, M. Zheng, J. Bindas, P. Schwarzenberger, and J.K. Kolls Critical role of IL-17 receptor signaling in acute TNBS-induced colitis Inflamm Bowel Dis 12 2006 382 388
193. A. Zhernakova, E.M. Festen, L. Franke, G. Trynka, C.C. van Diemen, and A.J. Monsuur Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP Am J Hum Genet 82 2008 1202 1210